Browsing by Author Cheng, PNM

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 3 to 13 of 13 < previous 
TitleAuthor(s)Issue DateViews
 
Contactin 1 modulates pegylated arginase resistance in small cell lung cancer through induction of epithelial-mesenchymal transition
Journal:Scientific Reports
XU, SLam, SKCheng, PNMHo, JCM
2019
28
 
der(Y)t(Y;1) is a nonrandom abnormality in myelodysplastic syndrome [4]
Journal:Cancer Genetics and Cytogenetics
Wei, DCCWan, TSKChan, LCCheng, PNM
1993
179
 
Endogenous arginase 2 as a biomarker for PEGylated arginase 1 treatment in squamous cell lung carcinoma xenograft models
Proceeding/Conference:Journal of Clinical Oncology
Ho, JCMXu, SCheng, PNMLam, SK
2018
47
 
In vitro effects of pegylated arginase in small cell lung cancer
Proceeding/Conference:Journal of Thoracic Oncology
Xu, SLam, SKCheng, PNMHo, JCM
2016
40
 
Inhibition of ornithine decarboxylase facilitates pegylated arginase treatment in lung adenocarcinoma xenograft models
Proceeding/Conference:Journal of Thoracic Oncology
Ho, JCMU, KPXu, SCheng, PNMLam, SK
2017
62
 
Pegylated Recombinant Human Arginase 1 Induces Autophagy and Apoptosis via the ROS-Activated AKT/mTOR Pathway in Bladder Cancer Cells
Journal:Oxidative Medicine and Cellular Longevity
Zhao, ZZhang, PLi, WWang, DKe, CLiu, YHo, JCMCheng, PNMXU, S
Editor(s):Quiles, JL
2021
12
 
Pegylated recombinant human hepatic arginase I (rhArg-peg 5,000 mw) inhibits human hepatocellular carcinoma in vitro and in vivo
Proceeding/Conference:The International Meeting of Hepatocellular Carcinoma
Cheng, PNMLo, TLeung, TPoon, RTP
2004
 
Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest
Journal:Cancer Letters
Lam, TLWong, GKYChong, HCCheng, PNMChoi, SCChow, TLKwok, SYPoon, RTPWheatley, DNLo, WHLeung, YC
2009
 
Remission of hepatocellular carcinoma with Arginine depletion induced by systemic release of endogenous hepatic arginase due to transheaptic embolization augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma
Proceeding/Conference:The International Meeting of Hepatocellular Carcinoma
Cheng, PNMLeung, TLo, TPoon, RTP
2004
97
 
Remission of hepatocellular carcinoma with Arginine depletion induced by systemic release of endogenous hepatic arginase due to transheaptic embolization augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma (
Journal:Asian Journal of Surgery
Cheng, PNMLeung, TLo, TPoon, RTP
2005
117
 
Suppression of tumour growth by pegylated arginase in malignant pleural mesothelioma
Proceeding/Conference:Journal of Thoracic Oncology
Ho, JCMU, KPXu, SCheng, PNMLam, SK
2017
53
Showing results 3 to 13 of 13 < previous